Arzeda In the News

Arzeda Raises $12 Million in Series A Round of Funding Led by OS Fund

Technology scale-up will unlock production of proteins that create sustainable stain-resistant paint, stronger Plexiglas, next-generation sweeteners, and purpose-built molecules that don’t yet exist SEATTLE, (July 20, 2017) Arzeda, The Protein Design Company™, today announced that it had raised $12 million in a Series A round of funding led by OS Fund and including Bioeconomy Capital


Biofuels Digest Names Arzeda Among Hottest Companies in Bioeconomy

Arzeda debuts in annual rankings of world’s most widely read biofuels and biobased chemicals daily journal   SEATTLE (November 7, 2016)— Arzeda, a synthetic biology company,  has been recognized among the top companies in the advanced bioeconomy in the annual rankings by Biofuels Digest, the world’s most widely read biofuels and biobased chemicals daily journal.


Arzeda produces 2 keystone molecules for Amyris-DARPA project

At ABLC Next in California, Arzeda reached a major technical milestone with Amyris as a part of a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement. Arzeda’s high-throughput, automated pipeline for protein engineering and pathway discovery has been validated by the production of two keystone molecules which will now be further optimized by Amyris.